Community Schedule

Enter at least 4 characters

3 results showing for: 'emtricitabine'

  1. Nucleosides Reverse Transcriptase Inhibitors
Efavirenz with emtricitabine and tenofovir disoproxil    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 111.
  • 3 to 6 month supply. Tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a fumarate)
    • Brand Fully subsidised brand. TEEVIR
    • Pharmacode2705508
    • Subsidy $106.88
    • Measure / Qty per 30
    • Brand Fully subsidised brand. TEEVIR (India) Unapproved medicine supplied under Section 29.
    • Pharmacode2727994
    • Subsidy $106.88
    • Measure / Qty per 30
    • Brand Fully subsidised brand. Tenofovir Efavirenz Emtricitabine(Mylan) Unapproved medicine supplied under Section 29.
    • Pharmacode2732041
    • Subsidy $106.88
    • Measure / Qty per 30
  • 3 to 6 month supply. Tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a maleate)
    • Brand Fully subsidised brand. Viatris
    • Pharmacode2644967
    • Subsidy $106.88
    • Measure / Qty per 30

Note: HIV treatment with antiretroviral medicines should only be initiated under the guidance of a clinician experienced in the management of HIV. Practitioners should refer to local health pathways and guidelines.

  1. Nucleosides Reverse Transcriptase Inhibitors
Emtricitabine    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 111.
  • 3 to 6 month supply. Cap 200 mg
    • Brand Fully subsidised brand. Emtriva
    • Pharmacode2250063
    • Subsidy $307.20
    • Measure / Qty per 30

Note: HIV treatment with antiretroviral medicines should only be initiated under the guidance of a clinician experienced in the management of HIV. Practitioners should refer to local health pathways and guidelines.

  1. HIV Prophylaxis and Treatment
Emtricitabine with tenofovir disoproxil    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 112.
- Up to 30 tab available on a PSO
- Subsidy by endorsement
  • 3 to 6 month supply. Tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a fumarate)
    • Brand Fully subsidised brand. Tenofovir Disoproxil Emtricitabine Mylan Unapproved medicine supplied under Section 29.
    • Pharmacode2719495
    • Subsidy $13.45
    • Measure / Qty per 30
  • 3 to 6 month supply. Tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a maleate)
    • Brand Fully subsidised brand. Tenofovir Disoproxil Emtricitabine Viatr
    • Pharmacode2638088
    • Subsidy $13.45
    • Measure / Qty per 30

Note: HIV treatment with antiretroviral medicines should only be initiated under the guidance of a clinician experienced in the management of HIV. Practitioners should refer to local health pathways and guidelines.

Note: Post-Exposure Prophylaxis (PEP) is not a registered indication for emtricitabine with tenofovir disoproxil and it cannot be supplied for this use under a standing order.

Funded on PSO for Post-Exposure Prophylaxis (PEP) only, supplied only by an authorised practitioner, and the PSO is endorsed accordingly.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply



Email enquiry@pharmac.govt.nz to provide feedback: compliments, suggestions and complaints.